Axsome Therapeutics (AXSM) Net Income Growth (5y) (2020 - 2026)
Axsome Therapeutics (AXSM) Net Income Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.25% |
| Dec 31, 2025 | 1.02% |
| Sep 30, 2025 | 27.48% |
| Jun 30, 2025 | 29.64% |
| Mar 31, 2025 | -12.57% |
| Dec 31, 2024 | -24.36% |
| Sep 30, 2024 | -2.82% |
| Jun 30, 2024 | -2.50% |
| Mar 31, 2024 | -44.48% |
| Dec 31, 2023 | -66.88% |
| Sep 30, 2023 | -45.85% |
| Jun 30, 2023 | -48.83% |
| Mar 31, 2023 | -7.90% |
| Dec 31, 2022 | -65.47% |
| Sep 30, 2022 | -68.91% |
| Jun 30, 2022 | -64.48% |
| Mar 31, 2022 | -52.93% |
| Dec 31, 2021 | -19.15% |
| Sep 30, 2021 | -134.01% |
| Jun 30, 2021 | -128.64% |